NL-OMON30924已完成3 期
Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHance with Magnevist in Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. - DETECT
Bracco-Byk0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •written Informed Consent
- •Female subject of 18 years or older
- •At least one suspicious or known breast lesion
- •Is planned to undergo histological diagnosis of breast lesions
排除标准
- •-has body weight > 100 Kg
- •-is pregnant or lactating
- •-has severe or end-stage organ failure
- •-has moderate to severe renal impairment
- •-is undergoing or has undergone radiotherapy within 18 months before exam 1
- •-is undergoing or has undergone chemotherapy/antitumural hormonal therapy within 6 months before exam 1
- •-has recieved or scheduled to receive any onther contrast medium 24 hours before or after exam1
- •-has history of breast surgery
研究者
相似试验
进行中（未招募）
不适用
Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHance® with Magnevist® in Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast (DETECT) - DETECTSuspected or known breast cancer in femalesMedDRA version: 9.1Level: LLTClassification code 10006188Term: Breast cancer female NOSEUCTR2006-004613-18-NLBracco Imaging S.p.A.130
进行中（未招募）
1 期
Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHance® with Magnevist® in Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast (DETECT) - DETECTEUCTR2006-004613-18-GBBracco Imaging S.p.A.130
进行中（未招募）
不适用
Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHancE with MagnevisT in Contrast-Enhanced MagnetiC Resonance Imaging MRI of the BreasT. - DETECT - - DETECT - MultiHance vs. Magnevist in Breast MRIpatiens with breast lesions which are highly suspicious or already known for malignancy which are requested for MRIMedDRA version: 6.1Level: PTClassification code 10006279EUCTR2006-004613-18-ITBRACCO IMAGING130
进行中（未招募）
不适用
Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHance® with Magnevist® in Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast (DETECT) - DETECTEUCTR2006-004613-18-DEBracco Imaging S.p.A.130
进行中（未招募）
3 期
A clinical trial to study the safety, efficacy and tolerability of the drug Ceftazidime-Avibactam(CAZ-AVI) versus Meropenem in patients with Nosocomial Pneumonia(NP) including Ventilator Associated Pneumonia(VAP).CTRI/2014/05/004622AstraZeneca AB